Autoantibodies against TRPC3 and ryanodine receptor in myasthenia gravis

Journal of Neuroimmunology

Volumn 200, Issue 1-2, 2008, Pages 142-144

  Takamori, Masaharu ^a  

^a Kanazawa Nishi Hospital   (Japan)

Author keywords

Calcium channels; Myasthenia gravis; Ryanodine receptor; Sarcoplasmic reticulum; Thymoma; Transient receptor potential canonical (TRPC)

Indexed keywords

1,4 DIHYDROPYRIDINE RECEPTOR; AUTOANTIBODY; CALCIUM CHANNEL; RYANODINE RECEPTOR; RYANODINE RECEPTOR 1; TRANSIENT RECEPTOR POTENTIAL CHANNEL 3;

ADULT; AGED; ARTICLE; CALCIUM TRANSPORT; CLINICAL ARTICLE; FEMALE; HUMAN; MALE; MUSCLE CONTRACTION; MYASTHENIA GRAVIS; PRIORITY JOURNAL; THYMOMA; THYMUS HYPERPLASIA;

ADOLESCENT; ADULT; AGED; AUTOANTIBODIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; MYASTHENIA GRAVIS; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL; TRPC CATION CHANNELS;

EID: 49849093409     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2008.06.001     Document Type: Article

References (21)

1. Bhat M.B., Zhao J., Takeshima H., and Ma J. Functional release channel formed by the carboxyl-terminal protein of ryanodine receptor. Biophys. J. 73 (1997) 1329-1336
2. Iwasa K., Komai K., and Takamori M. Spontaneous thymoma rat as a model for myasthenic weakness caused by anti-ryanodine receptor antibodies. Muscle Nerve 21 (1998) 1655-1660
3. Jaretzki III A., Barohn R.J., Ernstoff R.M., Kaminski H.J., Keesey J.C., Penn A.S., Sanders D.B., and (Task Force of the Myasthenia Gravis Foundation of America). Myasthenia gravis: recommendations for clinical research standards. Neurology 55 (2000) 16-23
4. Kusner L.L., Mygland Å., and Kaminski H.J. Ryanodine receptor gene expression thymomas. Muscle Nerve 21 (1998) 1299-1303
5. Lee E.H., Cherednichenko G., Pessah I.N., and Allen P.D. Functional coupling between TRPC3 and RyR1 regulates the expression of key triadic proteins. J. Biol. Chem. 281 (2006) 10042-10048
6. 2+ channel isoforms in mouse brain. NeuroReport 9 (1998) 507-515
7. Putney Jr. J.W. Inositol lipids and TRPC channel activation. Biochem. Soc. Symp. 74 (2007) 37-45
8. Romi F., Bø L., Skeie G.O., Myking A., Aarli J.A., and Gilhus N.E. Titin and ryanodine receptor epitopes are expressed in cortical thymoma along with costimulatory molecules. J. Neuroimmunol. 128 (2002) 82-89
9. Romi F., Skeie G.O., Gilhus N.E., and Aarli J.A. Striational antibodies in myasthenia gravis. Reactivity and possible clinical significance. Arch. Neurol. 62 (2005) 442-446
10. Romi F., Aarli J.A., and Gilhus N.E. Myasthenia gravis patients with ryanodine receptor antibodies have distinctive clinical features. Eur. J. Neurol. 14 (2007) 617-620
11. Sandow A. Excitation-contraction coupling in skeletal muscle. Pharmacol. Rev. 17 (1965) 265-320
12. Skeie G.O., Mygland Å., Treves S., Gilhus N.E., Aarli J.A., and Zorzato F. Ryanodine receptor antibodies in myasthenia gravis: epitope mapping and effect on calcium release in vitro. Muscle Nerve 27 (2003) 81-89
13. Takamori M. Immunology of ryanodine receptor and FK506 in myasthenia gravis. Curr. Topics Peptide Protein Res. 5 (2003) 187-199
14. Takamori M., Motomura M., Kawaguchi N., Nemoto Y., Hattori T., Yoshikawa H., and Otsuka K. Anti-ryanodine receptor antibodies and FK506 in myasthenia gravis. Neurology 62 (2004) 1894-1896
15. Takamori M., Motomura M., Fukudome T., and Yoshikawa H. Autoantibodies against M1 muscarinic acetylcholine receptor in myasthenic disorders. Eur. J. Neurol. 14 (2007) 1230-1235
16. Takeshima H., Nishimura S., Matsumoto T., Ishida H., Kangawa K., Minamino N., Matsuo S., Ueda M., Hanaoka M., Hirose T., and Numa S. Primary structure and expression from complementary DNA of skeletal muscle ryanodine receptor. Nature 339 (1989) 439-445
17. Trebak M., Bird G.S., McKay R.R., and Putney Jr. J.W. Comparison of human TRPC3 channels in receptor-activated and store-operated modes. Differential sensitivity to channel blockers suggests fundamental differences in channel composition. J. Biol. Chem. 277 (2002) 21617-21623
18. Vannier B., Zhu X., Brown D., and Birnbaumer L. The membrane topography of human transient receptor potential 3 as inferred from glycosylation-scanning mutagenesis and epitope immunocytocheminstry. J. Biol. Chem. 273 (1998) 8675-8679
19. Woo J.S., Kim D.H., Allen P.D., and Lee E.H. TRPC3-interacting triadic proteins in skeletal muscle. Biochem. J. 411 (2008) 399-405
20. 2+ entry. Cell 85 (1996) 661-671
21. 2+ release channel (ryanodine receptor) of skeletal muscle sarcoplasmic reticulum. J. Biol. Chem. 265 (1990) 2244-2256